ArticleClinical medicine (London, England)2026
Prevalence and predictive factors of chronic kidney disease among individuals with cardiometabolic risk factors: A multicenter cross-sectional study, North East Ethiopia.
Article in Clinical medicine (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic kidney disease (CKD) is a major global public health concern, affecting more than 9% of adults worldwide and contributing to rising morbidity, mortality, and healthcare costs. The burden is disproportionately higher in low-resource settings such as Sub-Saharan Africa, where limited diagnostic capacity leads to delayed detection and accelerated progression to kidney failure. In Ethiopia, existing evidence is largely confined to diabetic populations, with minimal data on other high-risk groups. This study aimed to determine the prevalence of CKD and its associated risk factors among individuals with cardio-metabolic risk factors.
methodsA facility-based cross-sectional study was conducted from 1 March to 30 September 2025. A total of 510 adults with at least one of the cardiometabolic risk factors were enroled to the study. Data were collected through structured interviews, clinical examination, laboratory testing, and abdominal ultrasonography. Estimated glomerular filtration rate (eGFR) was calculated using Chronic Kidney Disease Epidemiology Collaboration equation (CKD-EPI 2021). Logistic regression was used to identify predictors of CKD.
resultsThe mean age of study participants was 61.7 years and 22.35% of them were found to have chronic kidney disease. CKD Stages 3, 4, and 5 were present in 13.92%, 5.69%, and 2.75% of the study participants, respectively. Chronic kidney disease was associated with abnormal waist circumference (P = 0.040), hepatitis B infection (P = 0.021), type 2 diabetes (p = 0.001), hypertension (p = 0.021), and previous acute kidney injury (p = 0.0001). CONCLUSION AND RECOMMENDATIONS: The study demonstrated a substantial burden of CKD with more than one-fifth of adults found to have moderate to severe kidney function impairment. Early screening of high-risk individuals and targeted management should be strengthened. Urine albumin-to-creatinine ratio (UACR) testing, which is relatively simple method of CKD screening, should be made available to improve the early screening and detection of kidney disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.